Echocardiography
Cardiac CT may be safer vs. TEE during COVID-19 pandemic
Cardiac CT may be the ideal imaging technique during the COVID-19 pandemic compared with transesophageal echocardiography, according to a presentation at the Society of Cardiovascular Computed Tomography Annual Scientific Meeting.
3D echocardiography may predict right ventricular EF changes after cancer treatment
Measurements of right ventricular volume and strain from 3D echocardiography were linked to later changes in right ventricular ejection fraction, according to a study published in JACC: CardioOncology.
What is the clinical significance of abnormal ECG but normal echocardiography? Read the week’s top stories in cardiology
Researchers found that individuals who had positive ECG results and normal stress echocardiography had a slightly increased risk for adverse cardiac events. It was the week’s top story in cardiology.
Positive ECG, negative echocardiography may identify patients with elevated cardiac risk
Patients with positive ECG results and normal stress echocardiography had a slightly increased risk for adverse cardiac events, according to a study published in JAMA Internal Medicine.
Routine, selective cardiac MRI confer similar HF etiologies
Routine cardiac MRI did not result in more specific HF etiologies in patients with nonischemic HF compared with selective cardiac MRI, according to results of the OUTSMART-HF trial published in Circulation.
Long-term risk for VTE significant after HF hospitalization
Patients hospitalized for HF were found to have significantly elevated long-term risk for venous thromboembolism, regardless of ejection fraction.
Part of the Healio Network
Amyl Nitrate
Amyl nitrate can be given via inhalation to reduce afterload for diagnostic purposes in the cardiac catheterization laboratory to invoke an LV outflow tract gradient in hypertrophic obstructive cardiomyopathy patients.
Novel algorithm for HF screening receives FDA breakthrough designation
Eko announced that a novel ECG-based algorithm to screen for HF has been granted breakthrough device status from the FDA.
Apple Heart Study publication offers further insights on AF detection from wearables
Results of the Apple Heart Study that were presented earlier this year at the American College of Cardiology Scientific Session have been published in The New England Journal of Medicine.
System to aid echocardiography receives FDA clearance
Ventripoint Diagnostics announced its analysis system that works with standard echocardiography machines has been cleared for commercial use by the FDA.